Breaking News Instant updates and real-time market news.

2022-09-15 08:34:12 AIRI Air Industries / + 08:34 09/15/22 09/15 08:34 09/15/22 08:34	Air Industries wins two contracts worth $5M for aircraft components Air Industries announced that it has won two contracts with a combined total value of $5M. The company's Air Industries Machining, or AIM, subsidiary has been awarded a five-year long-term agreement to manufacture flight-critical assemblies for the Blackhawk helicopter, with an estimated value of $2.2M. AIM has manufactured this product for many years. The new LTA extends until December 31, 2027, replacing an existing LTA expiring at 2022 year-end. Air Industries also said its Sterling Engineering subsidiary has received a new order worth $2.8M for engine components to be used on the F404 jet engine. This engine, which powers frontline fighters and trainers around the world, has been in production for many years and is being used in the new Boeing-Saab T-7A Red Hawk advanced jet training aircraft.

2022-09-15 08:34:12

AIRI

Air Industries

/ +

08:34

09/15/22

09/15

08:34

09/15/22

08:34

Air Industries wins two contracts worth $5M for aircraft components

Air Industries announced that it has won two contracts with a combined total value of $5M. The company's Air Industries Machining, or AIM, subsidiary has been awarded a five-year long-term agreement to manufacture flight-critical assemblies for the Blackhawk helicopter, with an estimated value of $2.2M. AIM has manufactured this product for many years. The new LTA extends until December 31, 2027, replacing an existing LTA expiring at 2022 year-end. Air Industries also said its Sterling Engineering subsidiary has received a new order worth $2.8M for engine components to be used on the F404 jet engine. This engine, which powers frontline fighters and trainers around the world, has been in production for many years and is being used in the new Boeing-Saab T-7A Red Hawk advanced jet training aircraft.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Lazard names Ronald Temple as Chief Market Strategist » 06:50 12/06/22 12/06 06:50 12/06/22 06:50 LAZ Lazard $34.66 / -2.09 (-5.69%) Lazard announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals LAZ Lazard $34.66 / -2.09 (-5.69%) 11/10/22 Lazard reports preliminary AUM $204.6B as of October 31 10/18/22 Lazard secures new U.K. headquarters in Manchester Square 10/13/22 Lazard appoints Jami Miscik as senior advisor, geopolitical advisory 10/12/22 Lazard reports September 2022 AUM of $197.8B LAZ Lazard $34.66 / -2.09 (-5.69%) 07/18/22 Morgan Stanley Lazard downgraded to Underweight from Equal Weight at Morgan Stanley 07/13/22 Keefe Bruyette Lazard downgraded to Underperform from Market Perform at Keefe Bruyette 07/08/22 Piper Sandler Lazard price target lowered to $44 from $45 at Piper Sandler 04/07/22 Piper Sandler Lazard price target lowered to $45 from $49 at Piper Sandler LAZ Lazard $34.66 / -2.09 (-5.69%) 10/27/22 Lazard reports Q3 adjusted EPS $1.05, consensus 80c 07/28/22 Lazard reports Q2 adjusted EPS 92c, consensus 86c LAZ Lazard $34.66 / -2.09 (-5.69%) 09/15/22 Lazard poised to hire key banker from Citi Saudi Arabia, Bloomberg reports
Upgrade	PennyMac Financial upgraded to Overweight from Equal Weight at Wells Fargo » 06:49 12/06/22 12/06 06:49 12/06/22 06:49 PFSI PennyMac Financial $57.11 / -2 (-3.38%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options PFSI PennyMac Financial $57.11 / -2 (-3.38%) 10/28/22 PennyMac Financial rises 13.9% 10/28/22 PennyMac Financial rises 14.7% 10/03/22 PennyMac Financial names Jerry Halbrook as Chief Mortgage Innovation Officer 07/21/22 PennyMac Financial director sells $2M in common stock PFSI PennyMac Financial $57.11 / -2 (-3.38%) 10/28/22 Piper Sandler PennyMac Financial price target raised to $82 from $78 at Piper Sandler 10/17/22 Barclays PennyMac Financial price target lowered to $55 from $65 at Barclays 09/27/22 Barclays PennyMac Financial price target lowered to $65 from $73 at Barclays 07/11/22 Barclays PennyMac Financial price target lowered to $73 from $90 at Barclays PFSI PennyMac Financial $57.11 / -2 (-3.38%) 10/27/22 PennyMac Financial reports Q3 EPS $2.46, consensus $1.13 08/02/22 PennyMac Financial reports Q2 EPS $2.28, consensus $1.10 PFSI PennyMac Financial $57.11 / -2 (-3.38%) 10/11/22 PennyMac falls after Roddy Boyd warns of 'mounting' delinquencies PFSI PennyMac Financial $57.11 / -2 (-3.38%) 11/09/22 PennyMac Financial put volume heavy and directionally bearish 10/27/22 PennyMac Financial options imply 6.5% move in share price post-earnings 10/11/22 PennyMac Financial put volume heavy and directionally bearish 10/10/22 PennyMac Financial put volume heavy and directionally bearish
Recommendations	Silence Therapeutics price target lowered to $80 from $95 at H.C. Wainwright » 06:49 12/06/22 12/06 06:49 12/06/22 06:49 SLN Silence Therapeutics $18.00 / +0.85 (+4.96%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events SLN Silence Therapeutics $18.00 / +0.85 (+4.96%) 11/06/22 Silence Therapeutics presents new analysis from SLN360 Phase 1 single dose study 09/29/22 Silence reports preliminary results from single dose part of GEMINI II trial 09/19/22 Viracta Therapeutics announces CEO leadership succession 09/08/22 Silence Therapeutics granted Fast Track Designation for SLN124 by FDA SLN Silence Therapeutics $18.00 / +0.85 (+4.96%) 11/17/22 Chardan Silence Therapeutics price target lowered to $29 from $33 at Chardan 03/31/22 Chardan Silence Therapeutics initiated with a Buy at Chardan 03/22/22 H.C. Wainwright Silence Therapeutics price target lowered to $95 from $100 at H.C. Wainwright 12/12/22 ASH Annual Meeting & Expo 2022
Recommendations	Liberty Global price target raised to $20 from $18 at Citi » 06:48 12/06/22 12/06 06:48 12/06/22 06:48 LBTYA Liberty Global $19.46 / -0.21 (-1.07%) Citi analyst Georgios… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options LBTYA Liberty Global $19.46 / -0.21 (-1.07%) 11/02/22 Paramount, Virgin Media enter multiyear distribution partnership 11/01/22 Liberty Global reiterates 10% buyback floor for 2023 11/01/22 Liberty Global reaffirms all FY22 guidance targets 07/29/22 Liberty Global, Telefonica and Infravia set up JV to offer FTTH LBTYA Liberty Global $19.46 / -0.21 (-1.07%) 12/05/22 BofA Liberty Global downgraded to Neutral from Buy at BofA 12/01/22 JPMorgan Liberty Global downgraded to Neutral from Overweight at JPMorgan 10/17/22 Deutsche Bank Liberty Global price target lowered to $29.50 from $32 at Deutsche Bank 10/14/22 Citi Liberty Global initiated with a Neutral at Citi LBTYA Liberty Global $19.46 / -0.21 (-1.07%) 11/01/22 Liberty Global reports Q3 adjusted EBITDA $664M vs. $758.5M last year 07/28/22 Liberty Global confirms all full-year guidance metrics 07/28/22 Liberty Global reports Q2 adjusted EBITDA $649.8M, consensus $666.4M LBTYA Liberty Global $19.46 / -0.21 (-1.07%) 10/25/22 Liberty, Telefonica exploring sale of Cornerstone stake, Bloomberg reports LBTYA Liberty Global $19.46 / -0.21 (-1.07%) 12/01/22 Largest borrow rate increases among liquid names 09/28/22 Liberty Global call volume above normal and directionally bullish 09/15/22 Largest borrow rate increases among liquid names
Hot Stocks	Pfizer and Clear Creek Bio partnering on COVID-19 oral antiviral research » 06:47 12/06/22 12/06 06:47 12/06/22 06:47 PFE Pfizer $50.74 / -0.16 (-0.31%) Pfizer and Clear Creek… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE Pfizer $50.74 / -0.16 (-0.31%) 12/05/22 McCormick names Sarah Piper as Chief Human Relations Officer 12/01/22 Carrick Therapeutics closes $25M Series C financing 12/01/22 Carrick Therapeutics receives $35M investment from Pfizer 12/01/22 Roivant Sciences, Pfizer form new Vant company focused on developing RVT-3101 PFE Pfizer $50.74 / -0.16 (-0.31%) 11/17/22 Credit Suisse Pfizer initiated with an Outperform at Credit Suisse 11/15/22 BofA Moderna price target raised to $182 from $160 at BofA 11/03/22 KeyBanc Maravai Lifesciences price target lowered to $28 from $35 at KeyBanc 11/02/22 Barclays Pfizer price target raised to $49 from $44 at Barclays PFE Pfizer $50.74 / -0.16 (-0.31%) 11/01/22 Pfizer raises FY22 adjusted EPS view to $6.40-$6.50 from $6.30-$6.45 11/01/22 Pfizer reports Q3 adjusted EPS $1.78, consensus $1.39 10/31/22 Notable companies reporting before tomorrow's open 10/31/22 Notable companies reporting before tomorrow's open PFE Pfizer $50.74 / -0.16 (-0.31%) 12/02/22 Pfizer to invest over $2.5B at Belgium, Ireland plants, Reuters reports 12/01/22 Twitter offers advertisers big incentives to boost spending, WSJ reports 11/03/22 General Mills, Mondelez, Pfizer halt Twitter advertising, WSJ reports 10/26/22 Pfizer probed in Italy on allegations of hiding profit, Bloomberg says PFE Pfizer $50.74 / -0.16 (-0.31%) 12/02/22 What You Missed On Wall Street On Friday 12/02/22 What You Missed On Wall Street This Morning 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo 11/09/22 #SocialStocks: Shares responds as Meta axes 13% of workforce 12/07/22 Biopharma Spotlight: Global Large Cap Virtual Conference 12/12/22 ASH Annual Meeting & Expo 2022 PFE Pfizer $50.74 / -0.16 (-0.31%) 11/14/22 Pfizer call volume above normal and directionally bullish 11/01/22 Unusually active option classes on open November 1st 10/21/22 Unusually active option classes on open October 21st 08/19/22 Early notable gainers among liquid option names on August 19th
Hot Stocks	SQZ Biotechnologies receives FDA Fast Track Designation for eAPC candidate » 06:47 12/06/22 12/06 06:47 12/06/22 06:47 SQZ SQZ Biotechnologies $1.42 / -0.13 (-8.39%) SQZ Biotechnologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SQZ SQZ Biotechnologies $1.42 / -0.13 (-8.39%) 12/01/22 SQZ Biotechnologies announces strategic prioritization, resignation of CEO/CFO 10/03/22 SQZ Biotechnologies publishes preclinical research on SQZ AAC platform 09/12/22 SQZ Biotechnologies presents preclinical SQZ TIL data at ESMO 09/06/22 SQZ Biotechnologies names Chief Scientific Officer Howard Bernstein to board SQZ SQZ Biotechnologies $1.42 / -0.13 (-8.39%) 12/02/22 H.C. Wainwright SQZ Biotechnologies downgraded to Neutral from Buy at H.C. Wainwright 12/01/22 Chardan SQZ Biotechnologies price target lowered to $4 from $16 at Chardan 12/01/22 BofA SQZ Biotechnologies double-downgraded to Underperform at BofA 12/01/22 BofA SQZ Biotechnologies downgraded to Underperform from Buy at BofA SQZ SQZ Biotechnologies $1.42 / -0.13 (-8.39%) 11/09/22 SQZ Biotechnologies reports Q3 EPS (77c), consensus (83c) 08/04/22 SQZ Biotechnologies reports Q2 EPS (78c) vs (68c) last year
Initiation	Array Technologies initiated with an Overweight at Wells Fargo » 06:47 12/06/22 12/06 06:47 12/06/22 06:47 ARRY Array Technologies $21.85 / -0.37 (-1.67%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ARRY Array Technologies $21.85 / -0.37 (-1.67%) 11/08/22 Array Technologies appoints Jokinen to board of directors 10/17/22 Array Technologies disclosed resignation of COO Kenneth Stacherski 09/19/22 Array Technologies launches Array OmniTrack, Array STI H250 07/21/22 Array enters into settlement agreement with Nextracker, Flextronics ARRY Array Technologies $21.85 / -0.37 (-1.67%) 12/02/22 RBC Capital RBC Capital 'not surprised' by Commerce Department's finding on solar companies 12/01/22 Roth Capital U.S. to announce 'affirmative' finding in solar trade case, says Roth Capital 11/10/22 Morgan Stanley New California 'NEM 3.0' proposal 'screens positive,' says Morgan Stanley 11/09/22 Northland Array Technologies price target raised to $30 from $26 at Northland ARRY Array Technologies $21.85 / -0.37 (-1.67%) 11/08/22 Array Technologies sees FY22 adjusted EPS 32c-37c, consensus 30c 11/08/22 Array Technologies reports Q3 adjusted EPS 18c, consensus 10c 11/08/22 Notable companies reporting after market close 08/10/22 Array Technologies affirms FY22 EPS 25c-35c, consensus 31c ARRY Array Technologies $21.85 / -0.37 (-1.67%) 12/02/22 Chinese solar producers dodged U.S. tariffs, WSJ reports 09/15/22 Jehoshaphat Research short Array Technologies, questions 'accounting tricks' 06/27/22 German ministry says EU states agree to 40% renewables target, Reuters reports 06/06/22 White House to waive some solar panel tariffs for 24 months, Reuters reports ARRY Array Technologies $21.85 / -0.37 (-1.67%) 12/05/22 What You Missed This Week in EVs and Clean Energy 11/09/22 What You Missed On Wall Street On Wednesday 11/09/22 What You Missed On Wall Street This Morning 11/09/22 Fly Intel: Pre-market Movers ARRY Array Technologies $21.85 / -0.37 (-1.67%) 12/01/22 Array Technologies put volume heavy and directionally bearish 10/13/22 Array Technologies put volume heavy and directionally bearish 10/12/22 Array Technologies put volume heavy and directionally bearish 09/29/22 Array Technologies put volume heavy and directionally bearish
Initiation	Xponential Fitness initiated with a Buy at Citi » 06:46 12/06/22 12/06 06:46 12/06/22 06:46 XPOF Xponential Fitness $22.45 / +0.055 (+0.25%) Citi analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events XPOF Xponential Fitness $22.45 / +0.055 (+0.25%) 12/05/22 Xponential Fitness signs master franchise agreement in Japan for Rumble, AKT 11/04/22 Xponential Fitness signs master franchise agreement in Portugal for Club Pilates 10/20/22 Xponential Fitness signs master franchise pact in Kuwait 10/05/22 Xponential Fitness debuts workouts on Lululemon Studio XPOF Xponential Fitness $22.45 / +0.055 (+0.25%) 11/18/22 Baird Xponential Fitness price target raised to $30 from $26 at Baird 11/11/22 B. Riley Xponential Fitness price target raised to $30 from $29 at B. Riley 11/11/22 Piper Sandler Xponential Fitness price target raised to $36 from $34 at Piper Sandler 09/15/22 B. Riley Xponential Fitness initiated with Buy, $29 target at B. Riley XPOF Xponential Fitness $22.45 / +0.055 (+0.25%) 11/10/22 Xponential Fitness raises FY22 revenue view to $235M-$240M from $211M-$221M 11/10/22 Xponential Fitness reports Q3 adjusted EPS 10c, consensus 14c 08/11/22 Xponential Fitness raises FY22 revenue view to $211M-$221M from $201M-$211M 08/11/22 Xponential Fitness reports Q2 EPS 50c 07 Apr 12/12/22 Xponential Fitness
Hot Stocks	Snap, H&M partner for digital fashion collection » 06:46 12/06/22 12/06 06:46 12/06/22 06:46 SNAP Snap $10.11 / -0.385 (-3.67%) In a Monday blog post,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SNAP Snap $10.11 / -0.385 (-3.67%) 11/22/22 EC Chief von der Leyen, confirms TikTok's data transfers being investigated 11/17/22 Snap COO sells $1.2M in common stock 11/10/22 Senator Rubio, Representative Gallagher call for national TikTok ban 11/01/22 Snap up 6%, Meta up 4% after FCC commissioner says U.S. should ban TikTok SNAP Snap $10.11 / -0.385 (-3.67%) 10/21/22 UBS Snap price target lowered to $10 from $14 at UBS 10/21/22 Canaccord Snap price target lowered to $12 from $16 at Canaccord 10/21/22 Susquehanna Snap price target lowered to $8 from $11 at Susquehanna 10/21/22 Stifel Snap price target lowered to $9 from $14 at Stifel SNAP Snap $10.11 / -0.385 (-3.67%) 10/20/22 Snap reports Q3 adjusted EPS 8c, consensus (1c) 10/20/22 Notable companies reporting after market close 08/31/22 Snap says forward looking revenue visibility 'remains limited' 08/31/22 Snap sees Q3 revenue growth at 8% through August 29 SNAP Snap $10.11 / -0.385 (-3.67%) 11/15/22 FBI director tells U.S lawmakers 'extremely concerned' about TikTok, CNBC says 11/08/22 TikTok restructures U.S. business amid advertising slump, FT reports 11/01/22 TikTok spokesperson tells Axios Carr has 'no role' in confidential talks 11/01/22 FCC commissioner thinks CFIUS should ban TikTok, Axios reports SNAP Snap $10.11 / -0.385 (-3.67%) 11/23/22 #SocialStocks: TikTok data transfers under investigation in EU 11/16/22 What You Missed On Wall Street This Morning 11/02/22 #SocialStocks: Tracking the lasest news from Twitter after Musk's takeover 11/01/22 What You Missed On Wall Street On Tuesday SNAP Snap $10.11 / -0.385 (-3.67%) 11/08/22 Snap Inc. call volume above normal and directionally bullish 10/25/22 Notable open interest changes for October 25th 10/24/22 Snap Inc. call volume above normal and directionally bullish 10/24/22 Notable open interest changes for October 24th
Recommendations	iClick Interactive Asia price target lowered to $3.50 from $17 at Citi » 06:45 12/06/22 12/06 06:45 12/06/22 06:45 ICLK iClick Interactive Asia $2.75 / +0.05 (+1.85%) Citi analyst Nelson… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ICLK iClick Interactive Asia $2.75 / +0.05 (+1.85%) 11/30/22 iClick Interactive Asia regains compliance with Nasdaq listing rules 10/31/22 iClick Interactive Asia implements ADS ratio change 06/27/22 iClick Interactive Asia releases metaverse livestreaming mobile app Arohar 06/15/22 iClick Interactive Asia receives minimum bid price notice from Nasdaq ICLK iClick Interactive Asia $2.75 / +0.05 (+1.85%) 08/25/22 Benchmark iClick Interactive Asia downgraded to Hold from Buy at Benchmark 05/31/22 Benchmark iClick Interactive Asia price target lowered to $2 from $8 at Benchmark 03/24/22 Benchmark iClick Interactive Asia price target lowered to $8 from $12 at Benchmark 03/24/22 Alliance Global Partners Alliance Global downgrades iClick Interactive Asia pending greater clarity ICLK iClick Interactive Asia $2.75 / +0.05 (+1.85%) 11/30/22 iClick Interactive Asia reports Q3 EPS (10c), consensus ($1.34) 08/25/22 iClick Interactive Asia reports Q2 adjusted EPS (15c), consensus (6c) ICLK iClick Interactive Asia $2.75 / +0.05 (+1.85%) 08/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Recommendations	Comerica price target lowered to $80 from $90 at Citi » 06:43 12/06/22 12/06 06:43 12/06/22 06:43 CMA Comerica $66.51 / -3.65 (-5.20%) Citi analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CMA Comerica $66.51 / -3.65 (-5.20%) 08/30/22 Comerica appoints Von Hays as EVP, CLO, general counsel 08/29/22 Comerica appoints Kelly Gage as director of investor relations 07/20/22 Comerica rises 5.0% 06/13/22 Comerica to consolidate 22 of existing 432 U.S. bank locations CMA Comerica $66.51 / -3.65 (-5.20%) 12/05/22 Morgan Stanley Comerica initiated with an Equal Weight at Morgan Stanley 12/01/22 Wolfe Research Comerica price target raised to $80 from $79 at Wolfe Research 11/21/22 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 11/21/22 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James CMA Comerica $66.51 / -3.65 (-5.20%) 10/19/22 Comerica reports Q3 EPS $2.60, consensus $2.57 07/20/22 Comerica reports Q2 EPS $1.37, consensus $1.78 CMA Comerica $66.51 / -3.65 (-5.20%) 10/19/22 Fly Intel: Pre-market Movers 01/19/23 Comerica - CMA CMA Comerica $66.51 / -3.65 (-5.20%) 06/13/22 Early notable gainers among liquid option names on June 13th
Upgrade	Zoomlion upgraded to Buy from Hold at HSBC » 06:43 12/06/22 12/06 06:43 12/06/22 06:43 ZLIOY Zoomlion $4.65 / + (+0.00%) HSBC analyst Helen Fang… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	New Gold downgraded to Reduce from Hold at TD Securities » 06:42 12/06/22 12/06 06:42 12/06/22 06:42 NGD New Gold $1.15 / -0.09 (-7.29%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options NGD New Gold $1.15 / -0.09 (-7.29%) 10/12/22 New Gold reports Q3 gold equivalent output 91,021 ounces vs 105,628 last year 09/29/22 Cenovus to help advance sustainable energy opportunities for First Nations 09/07/22 New Gold provides drill results from program at New Afton Mine 07/11/22 New Gold cuts FY22 gold equivalent production view to 325,000-365,000 ounces NGD New Gold $1.15 / -0.09 (-7.29%) 10/14/22 National Bank New Gold price target raised to C$1.60 from C$1.50 at National Bank 10/13/22 National Bank New Gold price target raised to C$1.50 from C$1.40 at National Bank 10/03/22 National Bank New Gold price target raised to C$1.40 from C$1.20 at National Bank 10/03/22 RBC Capital New Gold upgraded to Outperform from Sector Perform at RBC Capital NGD New Gold $1.15 / -0.09 (-7.29%) 11/30/22 Largest borrow rate increases among liquid names
Hot Stocks	Meta threatens to pull news from platform if Congress passes journalism bill » 06:41 12/06/22 12/06 06:41 12/06/22 06:41 META Meta Platforms $122.47 / -1.015 (-0.82%) In a Monday tweet, Andy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options META Meta Platforms $122.47 / -1.015 (-0.82%) 12/05/22 Meta expands age verification test to Facebook Dating in U.S. 12/05/22 User reports indicate problems at Meta's Facebook, Downdetector says 11/28/22 Meta fined EUR265M over Facebook data leak involving more than 533M users 11/23/22 German regulator says Meta to allow VR headset without a Facebook account META Meta Platforms $122.47 / -1.015 (-0.82%) 11/15/22 Morgan Stanley Meta Platforms price target lowered to $100 from $105 at Morgan Stanley 11/10/22 Canaccord Meta Platforms price target lowered to $170 from $200 at Canaccord 11/09/22 Itau BBA Meta Platforms price target raised to $120 from $102 at Itau BBA 11/09/22 Baird Meta layoffs represent 'significant shift in strategy,' says Baird META Meta Platforms $122.47 / -1.015 (-0.82%) 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 10/26/22 Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B 10/26/22 Meta Platforms reports Q3 EPS $1.64, consensus $1.89 10/26/22 Notable companies reporting after market close META Meta Platforms $122.47 / -1.015 (-0.82%) 12/01/22 Meta attempted to settle E.U. antitrust investigations, Reuters reports 12/01/22 Zuckerberg says Apple's app policies 'not sustainable,' Axios reports 11/30/22 Meta giving up some offices at Manhattan's Hudson Yards, Bloomberg reports 11/22/22 H&R Block, TaxAct sending users' information to Facebook, The Markup reports META Meta Platforms $122.47 / -1.015 (-0.82%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 11/30/22 #SocialStocks: Twitter and Apple spar over advertising, censorship 11/23/22 #SocialStocks: TikTok data transfers under investigation in EU META Meta Platforms $122.47 / -1.015 (-0.82%) 12/02/22 Notable open interest changes for December 2nd 11/09/22 Early notable gainers among liquid option names on November 9th 11/09/22 Unusually active option classes on open November 9th 11/07/22 Early notable gainers among liquid option names on November 7th
Initiation	Norwegian Cruise Line assumed with an Overweight at JPMorgan » 06:40 12/06/22 12/06 06:40 12/06/22 06:40 NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) JPMorgan analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 11/28/22 OneSpaWorld enters seven-year contract with Norwegian Cruise Line 11/16/22 Norwegian Cruise Line CEO sells $1.06M in common stock 11/08/22 Norwegian Cruise Line expects to report net loss for Q4 11/08/22 Norwegian Cruise Line on track to generate positive adjusted FCF in Q4 NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 06:35 Today JPMorgan Royal Caribbean assumed with Underweight from Overweight at JPMorgan 11/22/22 Truist Norwegian Cruise Line price target raised to $21 from $19 at Truist 11/17/22 Credit Suisse Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse 11/14/22 UBS Norwegian Cruise Line price target raised to $24 from $15 at UBS NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 11/08/22 Norwegian Cruise Line sees Q4 reveue $1.4B-$1.5B, consensus $1.46B 11/08/22 Norwegian Cruise Line reports Q3 adjusted EPS (64c), consensus (70c) 08/09/22 Norwegian Cruise Line sees Q3 revenue $1.5B-$1.6B, consensus $1.88B 08/09/22 Norwegian Cruise Line reports Q2 adjusted EPS ($1.14), consensus (86c) NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 07/02/22 Not the time to bottom-fish cruise operator stocks, Barron's says NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 11/19/22 Buy/Sell: Wall Street's top 10 stock calls this week 11/17/22 What You Missed On Wall Street On Thursday 11/17/22 What You Missed On Wall Street This Morning 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 Norwegian Cruise Line 12/13/22 Norwegian Cruise Line NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 12/05/22 Early notable gainers among liquid option names on December 5th 11/08/22 Early notable gainers among liquid option names on November 8th 11/08/22 Unusually active option classes on open November 8th 10/26/22 Unusually active option classes on open October 26th
General news	Energy Action: » 06:40 12/06/22 12/06 06:40 12/06/22 06:40 $ECON Economic Data / + Energy Action: Oil prices… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says 10/10/22 JPMorgan CEO tells CNBC U.S. recession likely in 6 to 9 months 09/07/22 Fed Beige Book says price levels 'remained highly elevated' $ECON Economic Data / + 11/30/22 What You Missed On Wall Street On Wednesday 11/28/22 What You Missed On Wall Street On Monday 11/28/22 What You Missed On Wall Street This Morning 11/02/22 What You Missed On Wall Street On Wednesday
Syndicate	HTG Molecular files automatic mixed securities shelf 06:39 12/06/22 12/06 06:39 12/06/22 06:39 HTGM HTG Molecular / + ShowHide Related Items >><< Company News Street Research HTGM HTG Molecular / + 10/26/22 HTG Molecular enters partnership with OmiCure for transcriptomic data 07/19/22 HTG Molecular to host KOL event addressing drug candidate attrition 07/18/22 HTG Molecular announces amendment to senior loan facility 07/06/22 HTG Molecular releases whitepaper for transcriptome-informed approach HTGM HTG Molecular / + 07/22/22 Cantor Fitzgerald HTG Molecular price target lowered to $3.50 from $15 at Cantor Fitzgerald 05/16/22 H.C. Wainwright HTG Molecular price target lowered to $3 from $4 at H.C. Wainwright 03/30/22 H.C. Wainwright HTG Molecular price target lowered to $4 from $9 at H.C. Wainwright 03/30/22 Craig-Hallum HTG Molecular price target lowered to $3 from $8 at Craig-Hallum
Upgrade	Weichai Power upgraded to Buy from Hold at HSBC » 06:39 12/06/22 12/06 06:39 12/06/22 06:39 WEICY Weichai Power $10.55 / +0.02 (+0.19%) HSBC analyst Helen Fang… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research WEICY Weichai Power $10.55 / +0.02 (+0.19%) 06:08 Today Daiwa Weichai Power upgraded to Outperform from Hold at Daiwa 05/31/22 JPMorgan Weichai Power upgraded to Overweight from Underweight at JPMorgan
Upgrade	Sinotruk upgraded to Buy from Hold at HSBC » 06:38 12/06/22 12/06 06:38 12/06/22 06:38 SHKLY Sinotruk $67.10 / + (+0.00%) HSBC analyst Helen Fang… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SHKLY Sinotruk $67.10 / + (+0.00%) 04/04/22 JPMorgan Sinotruk downgraded to Underweight from Neutral at JPMorgan 02/27/22 Goldman Sachs Sinotruk upgraded to Buy from Neutral at Goldman Sachs
Initiation	Carnival assumed with a Neutral at JPMorgan » 06:38 12/06/22 12/06 06:38 12/06/22 06:38 CCL Carnival $9.67 / -0.33 (-3.30%) JPMorgan analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CCL Carnival $9.67 / -0.33 (-3.30%) 12/01/22 Holland America Line reports 'record' Black Friday bookings in the U.S. 11/29/22 Carnival says Cyber Monday bookings 50% above volume for Cyber Monday 2019 11/15/22 Carnival falls 11% to $9.95 after $1B convertible senior notes offering 11/03/22 Carnival says Arnold Donald to step down from board of directors CCL Carnival $9.67 / -0.33 (-3.30%) 11/17/22 Credit Suisse Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse 11/14/22 UBS Carnival price target raised to $16 from $8 at UBS 10/27/22 Tigress Financial Tigress Financial sees 45% 12-month upside in Carnival shares 10/12/22 UBS Carnival price target lowered to $8 from $11 at UBS CCL Carnival $9.67 / -0.33 (-3.30%) 09/30/22 Carnival sees net loss, breakeven to slightly negative adjusted EBITDA in Q4 09/30/22 Carnival reports Q3 EPS (65c), consensus (13c) 09/29/22 Notable companies reporting before tomorrow's open 09/29/22 Notable companies reporting before tomorrow's open 21 Jul CCL Carnival $9.67 / -0.33 (-3.30%) 10/24/22 Carnival's Costa Cruises canceling Asia departures, Bloomberg reports 07/02/22 Not the time to bottom-fish cruise operator stocks, Barron's says 06/13/22 Carnival CEO tells Bloomberg company is 'recession resilient' CCL Carnival $9.67 / -0.33 (-3.30%) 12/02/22 Sell these stocks now, proven algorithm says 11/19/22 Buy/Sell: Wall Street's top 10 stock calls this week 11/16/22 Fly Intel: Pre-market Movers 11/15/22 Fly Intel: After-Hours Movers CCL Carnival $9.67 / -0.33 (-3.30%) 12/05/22 Early notable gainers among liquid option names on December 5th 12/02/22 Carnival call volume above normal and directionally bullish 12/01/22 Carnival call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th

Hot Stocks	Sage Therapeutics, Biogen complete NDA to FDA for zuranolone » 06:37 12/06/22 12/06 06:37 12/06/22 06:37 SAGE Sage Therapeutics $43.54 / -0.05 (-0.11%) , BIIB Biogen $292.64 / -6.35 (-2.12%) Sage Therapeutics (SAGE)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SAGE BIIB SAGE Sage Therapeutics $43.54 / -0.05 (-0.11%) 11/08/22 Sage sees cash and equivalents of $1.3B at end of FY22 11/01/22 Sage Therapeutics appoints Laura Gault, M.D. as Chief Medical Officer 10/17/22 Sage Therapeutics and Biogen present Phase 3 zuranolone results in depression 09/19/22 Sage Therapeutics, Biogen present analyses on efficacy, safety of zuranolone BIIB Biogen $292.64 / -6.35 (-2.12%) 12/05/22 Biogen announces EMA accepted tofersen MAA to treat rare form of ALS 11/29/22 Eisai and Biogen present full results for Lecanemab phase 3 study in AD 11/10/22 Biogen names Viehbacher president, CEO 10/17/22 Biogen announces FDA's 3-month expansion of review filing for NDA for tofersen SAGE BIIB SAGE Sage Therapeutics $43.54 / -0.05 (-0.11%) 11/09/22 H.C. Wainwright Sage Therapeutics price target lowered to $50 from $55 at H.C. Wainwright 11/01/22 Loop Capital Sage Therapeutics initiated with a Hold at Loop Capital 08/03/22 Citi Sage Therapeutics price target lowered to $40 from $41 at Citi 08/02/22 Stifel Sage Therapeutics price target lowered to $56 from $58 at Stifel BIIB Biogen $292.64 / -6.35 (-2.12%) 12/02/22 JonesTrading Anavex price target raised to $80 from $40 at JonesTrading 12/01/22 Atlantic Equities Biogen price target raised to $295 from $220 at Atlantic Equities 11/30/22 Mizuho Mizuho says Biogen not mentioned in 90 minute lecanemab presentation 11/30/22 Jefferies Biogen price target raised to $350 from $325 at Jefferies SAGE BIIB SAGE Sage Therapeutics $43.54 / -0.05 (-0.11%) 11/08/22 Sage Therapeutics reports Q3 EPS ($2.31), consensus ($2.21) 08/02/22 Sage Therapeutics reports Q2 EPS ($2.13), consensus ($2.15) BIIB Biogen $292.64 / -6.35 (-2.12%) 10/25/22 Biogen raises FY22 EPS view to $16.50-$17.15, consensus $16.49 10/25/22 Biogen reports Q3 adjusted EPS $4.77, consensus $4.15 10/24/22 Notable companies reporting before tomorrow's open 10/24/22 Notable companies reporting before tomorrow's open BIIB BIIB Biogen $292.64 / -6.35 (-2.12%) 11/28/22 Second death linked to Eisai's lecanemab Alzheimer's drug, Science says 11/07/22 Biogen weighing new CEO options after talks with J&J exec hit impasse, STAT says 10/28/22 Investigator in Alzheimer's trial linked lecanemab to patient death, STAT says 10/07/22 Former J&J exec emerges as top candidate to become Biogen CEO, Statnews reports BIIB BIIB Biogen $292.64 / -6.35 (-2.12%) 11/30/22 Fly Intel: Pre-market Movers 11/28/22 Fly Intel: Pre-market Movers 11/14/22 What You Missed On Wall Street On Monday 11/14/22 What You Missed On Wall Street This Morning 12/07/22 Biopharma Spotlight: Global Large Cap Virtual Conference 08:00 Today Biogen - BIIB 08:00 Today Sage Therapeutics - SAGE 12/15/22 Sage Therapeutics BIIB BIIB Biogen $292.64 / -6.35 (-2.12%) 11/30/22 Early notable gainers among liquid option names on November 30th 11/14/22 Early notable gainers among liquid option names on November 14th 10/13/22 Early notable gainers among liquid option names on October 13th 09/29/22 Unusually active option classes on open September 29th
Hot Stocks	Whitestone REIT provides update on disposition activities » 06:37 12/06/22 12/06 06:37 12/06/22 06:37 WSR Whitestone REIT $9.57 / -0.245 (-2.50%) Whitestone REIT has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research WSR Whitestone REIT $9.57 / -0.245 (-2.50%) 11/10/22 Whitestone REIT releases 2022 ESG report WSR Whitestone REIT $9.57 / -0.245 (-2.50%) 12/05/22 Truist Whitestone REIT price target raised to $10 from $9 at Truist 12/02/22 Truist Whitestone REIT price target raised to $10 from $9 at Truist 08/30/22 Truist Truist starts Whitestone REIT at Hold, sees challenging 2023 setup 08/30/22 Truist Whitestone REIT initiated with a Hold at Truist
Hot Stocks	Editas Medicine's EDIT-301 shows safety and efficacy in sickle cell disease » 06:36 12/06/22 12/06 06:36 12/06/22 06:36 EDIT Editas Medicine $9.83 / -0.425 (-4.15%) Editas Medicine announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EDIT Editas Medicine $9.83 / -0.425 (-4.15%) 11/17/22 Editas sinks 17% to $10.11 after pausing BRILLIANCE study enrollment 11/17/22 Editas Medicine announces clinical data from Phase 1/2 BRILLIANCE trial 10/18/22 Editas Medicine rises after report of talks to sell preclinical oncology assets 10/13/22 Editas Medicine presents preclinical data on EDIT-103 for RHO-adRP EDIT Editas Medicine $9.83 / -0.425 (-4.15%) 12/05/22 Credit Suisse Editas Medicine assumed with a Neutral at Credit Suisse 11/18/22 Morgan Stanley Editas Medicine price target lowered to $8 from $10 at Morgan Stanley 11/18/22 BofA Editas' EDIT-101 setback 'not the end of the story,' says BofA 11/18/22 RBC Capital Editas Medicine price target lowered to $14 from $32 at RBC Capital EDIT Editas Medicine $9.83 / -0.425 (-4.15%) 11/02/22 Editas Medicine reports Q3 EPS (81c), consensus (86c) 08/03/22 Editas Medicine reports Q2 EPS (78c), consensus (82c) EDIT Editas Medicine $9.83 / -0.425 (-4.15%) 10/18/22 Editas in talks to sell preclinical oncology assets, Endpoints News says 07/25/22 Researchers warn CRISPR gene editing may trigger cancer, Jerusalem Post says EDIT Editas Medicine $9.83 / -0.425 (-4.15%) 11/21/22 Biotech Alert: Searches spiking for these stocks today 11/18/22 What You Missed On Wall Street On Friday 11/18/22 What You Missed On Wall Street This Morning 11/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:00 Today Editas Medicine - EDIT
Hot Stocks	X-energy to go public via merger with Ares Acquisition » 06:36 12/06/22 12/06 06:36 12/06/22 06:36 AAC Ares Acquisition $10.04 / -0.005 (-0.05%) X Energy Reactor Company,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	Royal Caribbean assumed with Underweight from Overweight at JPMorgan » 06:35 12/06/22 12/06 06:35 12/06/22 06:35 RCL Royal Caribbean $59.44 / -1.07 (-1.77%) , NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) JPMorgan analyst Daniel… JPMorgan analyst Daniel Adam double downgraded Royal Caribbean (RCL) to Underweight from Overweight with a price target of $47, down from $106, after assuming coverage of the name. Despite roughly $10B of capital raises so far this year and free cash flow generation that should cover most, but not all, of its future commitments, Royal could face a $400M funding shortfall by the end of next year, Adam tells investors in a research note. Additionally, in order to achieve its investment grade credit rating target by 2025, Royal likely needs to raise an additional $3.5B, via either equity or asset sales, says the analyst. He says that at current levels, a $3.5B equity deal would be 20% dilutive to shareholders. Adam prefers Norwegian Cruise Line (NCLH) to Royal Caribbean, as he sees near-term funding requirements for the former as "less onerous." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options RCL NCLH RCL Royal Caribbean $59.44 / -1.07 (-1.77%) 12/01/22 Royal Caribbean International says bookings records set for third time in 2022 11/10/22 Royal Caribbean opens $125M cruise terminal in Galveston with Allure of the Seas 11/03/22 Royal Caribbean sees returning to historical load factors in early summer 2023 11/03/22 Royal Caribbean: Trifecta program to increase adjusted EPS to double digits NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 11/28/22 OneSpaWorld enters seven-year contract with Norwegian Cruise Line 11/16/22 Norwegian Cruise Line CEO sells $1.06M in common stock 11/08/22 Norwegian Cruise Line expects to report net loss for Q4 11/08/22 Norwegian Cruise Line on track to generate positive adjusted FCF in Q4 RCL NCLH RCL Royal Caribbean $59.44 / -1.07 (-1.77%) 11/22/22 Truist Royal Caribbean price target raised to $62 from $58 at Truist 11/17/22 Credit Suisse Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse 11/14/22 UBS Royal Caribbean price target raised to $76 from $56 at UBS 10/21/22 Tigress Financial Royal Caribbean shares have upside to $80, says Tigress Financial NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 11/22/22 Truist Norwegian Cruise Line price target raised to $21 from $19 at Truist 11/17/22 Credit Suisse Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse 11/14/22 UBS Norwegian Cruise Line price target raised to $24 from $15 at UBS 11/11/22 Deutsche Bank Norwegian Cruise Line price target lowered to $14 from $16 at Deutsche Bank RCL NCLH RCL Royal Caribbean $59.44 / -1.07 (-1.77%) 11/03/22 Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c) 11/03/22 Royal Caribbean reports Q3 adjusted EPS 26c, consensus 19c 11/02/22 Notable companies reporting before tomorrow's open 11/02/22 Notable companies reporting before tomorrow's open NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 11/08/22 Norwegian Cruise Line sees Q4 reveue $1.4B-$1.5B, consensus $1.46B 11/08/22 Norwegian Cruise Line reports Q3 adjusted EPS (64c), consensus (70c) 08/09/22 Norwegian Cruise Line sees Q3 revenue $1.5B-$1.6B, consensus $1.88B 08/09/22 Norwegian Cruise Line reports Q2 adjusted EPS ($1.14), consensus (86c) RCL NCLH RCL Royal Caribbean $59.44 / -1.07 (-1.77%) 08/17/22 Royal Caribbean seeks approval to sail again in Hong Kong, SCMP reports 08/13/22 Royal Caribbean among companies at risk of liquidity squeeze, Barron's says 07/02/22 Not the time to bottom-fish cruise operator stocks, Barron's says NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 07/02/22 Not the time to bottom-fish cruise operator stocks, Barron's says RCL NCLH RCL Royal Caribbean $59.44 / -1.07 (-1.77%) 12/02/22 Sell these stocks now, proven algorithm says 11/19/22 Buy/Sell: Wall Street's top 10 stock calls this week 11/18/22 Sell these stocks now, proven algorithm says 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 11/19/22 Buy/Sell: Wall Street's top 10 stock calls this week 11/17/22 What You Missed On Wall Street On Thursday 11/17/22 What You Missed On Wall Street This Morning 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 Norwegian Cruise Line 12/13/22 Norwegian Cruise Line RCL NCLH RCL Royal Caribbean $59.44 / -1.07 (-1.77%) 11/03/22 Unusually active option classes on open November 3rd 10/18/22 Early notable gainers among liquid option names on October 18th 10/10/22 Royal Caribbean put volume heavy and directionally bearish 10/10/22 Unusually active option classes on open October 10th NCLH Norwegian Cruise Line $16.22 / -0.325 (-1.96%) 12/05/22 Early notable gainers among liquid option names on December 5th 11/08/22 Early notable gainers among liquid option names on November 8th 11/08/22 Unusually active option classes on open November 8th 10/26/22 Unusually active option classes on open October 26th

Events

Earnings calls, analyst events, roadshows and more

WDH
Today at 07:00

Waterdrop - WDH Conference Calls
SAGE
Today at 08:00

Sage Therapeutics - SAGE Conference Calls
CLDX
Today at 08:00

Celldex - CLDX Conference Calls
HEPS
Today at 08:00

Hepsiburada - HEPS Conference Calls
EDIT
Today at 08:00

Editas Medicine - EDIT Conference Calls
JILL
Today at 08:00

J.Jill - JILL Conference Calls
LILM
Today at 08:00

Lilium - LILM Conference Calls
BIIB
Today at 08:00

Biogen - BIIB Conference Calls
EGRX
Today at 08:00

Eagle Pharmaceuticals Firm Sponsored Meetings

Lotte New York Palace Hotel, New York, NY
ALCO
Today at 08:30

Alico - ALCO Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	TOPS X TOPS TOP Ships Spot Secondary Managers: Maxim Priced at: $2.00 6.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Air Industries wins two contracts worth $5M for aircraft components

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access